Financial Advocates Investment Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,662
Closed -$534K 715
2022
Q1
$534K Buy
13,662
+4,106
+43% +$159K 0.04% 422
2021
Q4
$438K Sell
9,556
-2,181
-19% -$104K 0.03% 516
2021
Q3
$556K Sell
11,737
-829
-7% -$38.7K 0.04% 456
2021
Q2
$583K Sell
12,566
-924
-7% -$41.8K 0.04% 448
2021
Q1
$592K Sell
13,490
-650
-5% -$29.5K 0.04% 441
2020
Q4
$581K Sell
14,140
-10
-0.1% -$390 0.04% 415
2020
Q3
$527K Buy
14,150
+5,040
+55% +$186K 0.05% 371
2020
Q2
$313K Buy
+9,110
New +$283K 0.03% 456
2018
Q1
Sell
-1,860
Closed -$62K 500
2017
Q4
$62K Buy
+1,860
New +$61.8K 0.01% 476

Other funds holding FFTY

Financial Advocates Investment Management's FFTY Position: Q2 2022 in Review

Financial Advocates Investment Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2022, closing a stake of 13,662 shares — an estimated $534K sold.

Financial Advocates Investment Management first reported a position in FFTY in Q4 2017 and held it in 9 quarters. The position peaked at $592K in Q1 2021. 58 funds tracked by Wall St. Rank hold FFTY as of Q2 2022.

  • Financial Advocates Investment Management reported no remaining CapForce IBD 50 ETF position as of Q2 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 13,662 CapForce IBD 50 ETF shares in Q2 2022, an estimated $534K.
  • Financial Advocates Investment Management first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 9 quarters.
  • Financial Advocates Investment Management's CapForce IBD 50 ETF position peaked at $592K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2022.

Based on Financial Advocates Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.